Similar articles

• [Procedures and methods of benefit assessments for medicines in Germany - a comment - letter no. 2].

  Schünemann HJ, Kunz R, Falck-Ytter Y. Schünemann HJ, et al. Dtsch Med Wochenschr. 2009 Feb;134(7):319-20; author reply 320. doi: 10.1055/s-0028-1124001. Epub 2009 Feb 5. Dtsch Med Wochenschr. 2009. PMID: 19197817 German. No abstract available.
• Response to the expertise: procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen.

  Koch K, Lange S. Koch K, et al. Eur J Health Econ. 2009 May;10(2):233-6. doi: 10.1007/s10198-008-0142-1. Eur J Health Econ. 2009. PMID: 19123011 No abstract available.
• Procedures and methods of benefit assessments for medicines in Germany: give the child a name.

  Schünemann H, Kunz R, Falck-Ytter Y, Santesso N. Schünemann H, et al. Eur J Health Econ. 2009 May;10(2):237-8. doi: 10.1007/s10198-009-0147-4. Eur J Health Econ. 2009. PMID: 19290557 No abstract available.
• [Clinical economics--a guideline for economic management in the clinic and general practice].

  Porzsolt F. Porzsolt F. Med Klin (Munich). 1996 Aug 15;91(8):531-5. Med Klin (Munich). 1996. PMID: 8965754 Review. German. No abstract available.
• Quality management in complementary and integrative medicine.

  Witt CM, Berghoefer A. Witt CM, et al. Forsch Komplementmed. 2009 Jun;16(3):190-4. doi: 10.1159/000219817. Epub 2009 Jun 3. Forsch Komplementmed. 2009. PMID: 19657204 Review.